A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer

NCT00369889 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Thymic Cancer
Thymoma

Interventions

DRUG: bevacizumab
DRUG: Erlotinib

Sponsor

Indiana University

Collaborators

[object Object]